Overview Financials News + Filings IR Vault Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
|
|
ARENA PHARMACEUTICALS INC (ARNA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/21/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/16/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/16/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/16/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/16/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/11/2022 |
4
| Nova Tina Susan (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 17,776 shares
@ $0
Disposed of 3,067 shares
@ $0
Disposed/sold 4,800 options to buy
@ $84, valued at
$403.2k
Disposed/sold 15,000 options to buy
@ $13.6, valued at
$204k
Disposed/sold 5,000 options to buy
@ $49.17, valued at
$245.9k
Disposed/sold 5,000 options to buy
@ $56.5, valued at
$282.5k
Disposed/sold 5,000 options to buy
@ $61.31, valued at
$306.6k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| FETZER OLIVER (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 1,525 shares
@ $0
Disposed of 8,167 shares
@ $0
Disposed/sold 7,500 options to buy
@ $14.6, valued at
$109.5k
Disposed/sold 4,167 options to buy
@ $14.6, valued at
$60.8k
Disposed/sold 15,000 options to buy
@ $13.6, valued at
$204k
Disposed/sold 5,000 options to buy
@ $49.17, valued at
$245.9k
Disposed/sold 5,000 options to buy
@ $56.5, valued at
$282.5k
Disposed/sold 5,000 options to buy
@ $61.31, valued at
$306.6k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 3,628 shares
@ $0
Disposed of 1,116 shares
@ $0
Disposed of 8,167 shares
@ $0
Disposed/sold 2,500 options to buy
@ $44.79, valued at
$112k
Disposed/sold 4,583 options to buy
@ $44.79, valued at
$205.3k
Disposed/sold 5,000 options to buy
@ $56.5, valued at
$282.5k
Disposed/sold 5,000 options to buy
@ $61.31, valued at
$306.6k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| Knobil Katharine (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 2,939 shares
@ $0
Disposed of 3,882 shares
@ $0
Disposed/sold 2,500 options to buy
@ $61.31, valued at
$153.3k
Disposed/sold 5,000 options to buy
@ $61.31, valued at
$306.6k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| Jarrett Jennifer (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 8,150 shares
@ $0
Disposed of 3,067 shares
@ $0
Disposed/sold 7,500 options to buy
@ $13.6, valued at
$102k
Disposed/sold 15,000 options to buy
@ $13.6, valued at
$204k
Disposed/sold 5,000 options to buy
@ $49.17, valued at
$245.9k
Disposed/sold 5,000 options to buy
@ $56.5, valued at
$282.5k
Disposed/sold 5,000 options to buy
@ $61.31, valued at
$306.6k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 8,150 shares
@ $0
Disposed of 3,067 shares
@ $0
Disposed/sold 7,500 options to buy
@ $14.6, valued at
$109.5k
Disposed/sold 4,167 options to buy
@ $14.6, valued at
$60.8k
Disposed/sold 15,000 options to buy
@ $13.6, valued at
$204k
Disposed/sold 5,000 options to buy
@ $49.17, valued at
$245.9k
Disposed/sold 5,000 options to buy
@ $56.5, valued at
$282.5k
Disposed/sold 5,000 options to buy
@ $61.31, valued at
$306.6k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| Schoch Steven J (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 4,600 shares
@ $0
Disposed/sold 3,601 options to buy
@ $65.19, valued at
$234.7k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| Dallas Jayson Donald Alexander (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 4,085 shares
@ $0
Disposed of 3,067 shares
@ $0
Disposed/sold 7,500 options to buy
@ $14.6, valued at
$109.5k
Disposed/sold 4,167 options to buy
@ $14.6, valued at
$60.8k
Disposed/sold 15,000 options to buy
@ $13.6, valued at
$204k
Disposed/sold 5,000 options to buy
@ $49.17, valued at
$245.9k
Disposed/sold 5,000 options to buy
@ $56.5, valued at
$282.5k
Disposed/sold 5,000 options to buy
@ $61.31, valued at
$306.6k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| Ouzren Nawal (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 890 shares
@ $0
Disposed of 3,665 shares
@ $0
Disposed/sold 2,500 options to buy
@ $83.95, valued at
$209.9k
Disposed/sold 1,666 options to buy
@ $83.95, valued at
$139.9k
Disposed/sold 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 03/11/2022 |
4
| Manion Douglas J. (EVP Research & Development) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 15,000 shares
@ $0
Disposed of 21,462 shares
@ $0
Disposed/sold 90,000 options to buy
@ $48.12, valued at
$4.3M
Disposed/sold 15,200 options to buy
@ $0 |
|
| 03/11/2022 |
4
| Stelzer Laurie (EVP & CFO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 9,086 shares
@ $0
Disposed of 6,660 shares
@ $0
Disposed of 21,462 shares
@ $0
Disposed/sold 132,000 options to buy
@ $36.33, valued at
$4.8M
Disposed/sold 38,850 options to buy
@ $80.08, valued at
$3.1M
Disposed/sold 15,200 options to buy
@ $0 |
|
| 03/11/2022 |
4
| Munshi Amit (President and CEO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Gifted 10,500 shares
@ $98.51, valued at
$1M
Disposed of 250 shares
@ $0
Disposed of 28,800 shares
@ $0
Disposed of 85,847 shares
@ $0
Disposed/sold 138,139 options to buy
@ $15.5, valued at
$2.1M
Disposed/sold 56,861 options to buy
@ $14.6, valued at
$830.2k
Disposed/sold 310,000 options to buy
@ $35.6, valued at
$11M
Disposed/sold 285,000 options to buy
@ $40.94, valued at
$11.7M
Disposed/sold 270,000 options to buy
@ $44.6, valued at
$12M
Disposed/sold 168,000 options to buy
@ $80.08, valued at
$13.5M
Disposed/sold 42,000 options to buy
@ $0 |
|
| 03/11/2022 |
4
| Schmidt Joan (EVP, General Counsel & Sec) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 8,165 shares
@ $0
Disposed of 6,660 shares
@ $0
Disposed of 21,462 shares
@ $0
Disposed/sold 132,000 options to buy
@ $41.25, valued at
$5.4M
Disposed/sold 38,850 options to buy
@ $80.08, valued at
$3.1M
Disposed/sold 15,200 options to buy
@ $0 |
|
| 03/11/2022 |
4
| Aurentz Vincent (Executive VP and CBO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 27,842 shares
@ $0
Disposed of 6,660 shares
@ $0
Disposed of 21,462 shares
@ $0
Disposed/sold 45,000 options to buy
@ $17.1, valued at
$769.5k
Disposed/sold 77,000 options to buy
@ $14.6, valued at
$1.1M
Disposed/sold 94,976 options to buy
@ $35.6, valued at
$3.4M
Disposed/sold 75,000 options to buy
@ $40.94, valued at
$3.1M
Disposed/sold 70,000 options to buy
@ $44.6, valued at
$3.1M
Disposed/sold 38,850 options to buy
@ $80.08, valued at
$3.1M
Disposed/sold 15,200 options to buy
@ $0 |
|
| 03/11/2022 |
4
| Lisicki Robert (EVP, Chief Commercial Officer) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Disposed of 9,441 shares
@ $0
Disposed of 6,660 shares
@ $0
Disposed of 21,462 shares
@ $0
Disposed/sold 110,000 options to buy
@ $40.95, valued at
$4.5M
Disposed/sold 75,000 options to buy
@ $40.94, valued at
$3.1M
Disposed/sold 70,000 options to buy
@ $44.6, valued at
$3.1M
Disposed/sold 38,850 options to buy
@ $80.08, valued at
$3.1M
Disposed/sold 15,200 options to buy
@ $0 |
|
| 03/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/11/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/11/2022 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 03/11/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/11/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/11/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/11/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
|
|
|